Abstract
Malignant hyperthermia (MH) is a rare myogenic hypermetabolic syndrome that is associated with certain commonly used anesthetic agents and muscle relaxants. Although the first case of MH was noted over 60 years ago, the syndrome was not described in the literature until 1960 by Denborough and Lovell.1 Since then, the pathophysiology and etiology have been studied and reviewed extensively. Treatment of MH before 1975 was primarily oriented toward correction of physiologic derangements. Mortality rates were characteristically 60% to 80%. Dantrolene sodium was added to the treatment protocol following successful use in MH-susceptible (MHS) pigs by Harrison2 in 1975 and later that same year in MHS humans by Britt.8 Since its approval by the FDA in 1979 for use in the treatment of MH, dantrolene has led to a dramatic decrease in morbidity and mortality caused by MH. This survey evaluates the pre-dantrolene and post-dantrolene experience with MH in the greater Kansas City area.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Denborough MA, Lovell RR (1960) Anaesthetic deaths in a family. Lancet 2:45
Harrison GG (1975) Control of malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth 47:62–65
Britt BA (1979) Etiology and pathophysiology of malignant hyperthermia. Fed Proc 38:44–48
Williams CH (1977) The development of an animal model for the fulminant hyperthermia-stress syndrome, in Henschel EO (ed) Malignant Hyperthermia: Current Concepts. New York: Appleton-Century-Crofts, pp 117–140
Ording H (1985) Incidence of malignant hyperthermia in Denmark. Anesth Analg 64: 700–704
Wingard DW (1977) Malignant hyperthermia-acute stress syndrome of man? in Henschel EO (ed) Malignant Hyperthermia: Current Concepts. New York: Appleton-Century-Crofts, pp 79–95
Williams CH (1976) Some observations on the etiology of fulminant hyperthermia-stress syndrome. Perspect Biol Med 20:120–130
Britt BA, Kalow W (1970) Malignant hyperthermia: A statistical review. Can Anaesth Soc J 17: 293–315
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Zukaitis, M.G., Hoech, G.P., Robinson, J.D. (1988). Malignant Hyperthermia: Pre- and Post-Dantrolene. In: Williams, C.H. (eds) Experimental Malignant Hyperthermia. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3738-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3738-9_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8327-0
Online ISBN: 978-1-4612-3738-9
eBook Packages: Springer Book Archive